Perceptive Advisors LLC Immatics N.V. Transaction History
Perceptive Advisors LLC
- $4.77 Billion
- Q1 2024
A detailed history of Perceptive Advisors LLC transactions in Immatics N.V. stock. As of the latest transaction made, Perceptive Advisors LLC holds 4,582,409 shares of IMTX stock, worth $53.2 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
4,582,409
Previous 3,491,500
31.24%
Holding current value
$53.2 Million
Previous $36.8 Million
31.0%
% of portfolio
1.01%
Previous 0.9%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
85Shares Held
68.8MCall Options Held
507KPut Options Held
170K-
Rtw Investments, LP New York, NY10MShares$116 Million1.69% of portfolio
-
Wellington Management Group LLP Boston, MA8.33MShares$96.8 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$74.9 Million0.86% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.3MShares$73.3 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.23MShares$37.5 Million0.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $886M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...